Related Experiment Video
Updated: Jan 16, 2026

06:38
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
12.5K
Trimethylamine N-oxide detection for early prediction of renal function utilizing a three-dimensional localized
Wei-Cheng Lin1,2, Wei-Lun Yen3, Yun-Yu Hsieh3
1Department of Trauma and Emergency, Chang Gung Memorial Hospital, Linko, 33302, Taiwan. weiclin@mail.cgu.edu.tw.
Mikrochimica Acta
|October 5, 2025
Summary
A novel Micro-Electro-Mechanical Systems (MEMS) biosensor uses a 3D localized electronic structure (3DLES) array to detect trimethylamine N-oxide (TMAO) in biological fluids. This cost-effective device enables rapid, reliable, and sensitive at-home renal function pre-screening.
Area of Science:
- Biomedical Engineering
- Biosensor Technology
- Analytical Chemistry
Background:
- Trimethylamine N-oxide (TMAO) is a biomarker associated with renal function.
- Current methods for TMAO detection can be complex and time-consuming.
- There is a need for rapid, sensitive, and accessible diagnostic tools for non-clinical settings.
Purpose of the Study:
- To introduce a novel Micro-Electro-Mechanical Systems (MEMS) biosensor architecture.
- To develop a biosensor capable of detecting low concentrations of TMAO in biological fluids.
- To enable early-stage renal function assessment through metabolic profiling.
Main Methods:
- Utilized a three-dimensional localized electronic structure (3DLES) array biosensor.
- Incorporated a modified Cole-Cole model to quantify enzymatic impedance effects.
- Integrated on-chip signal processing for rapid detection within 1 second.
Main Results:
- Achieved high sensitivity (320 ADC units/μM) and low detection limit (0.2 μM) for TMAO.
- Demonstrated high reliability with 98.1% repetition and low signal drift.
- Showed excellent agreement with cyclic voltammetry and mass spectrometry (R²=0.954).
Conclusions:
- The 3DLES biosensor offers a reliable and effective method for TMAO quantification.
- The device is suitable for early-stage renal function assessment in non-clinical settings.
- This compact and cost-effective biosensor presents a promising approach for at-home pre-screening.

